Statins and dilated cardiomyopathy: do we have enough data?

Author： Bielecka-Dabrowa Agata   Mikhailidis Dimitri P   Hannam Simon   Aronow Wilbert S   Rysz Jacek   Banach Maciej  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.3, 2011-03, pp. : 315-323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Do Statins Have a Role in the Management of Diastolic Dysfunction?

By Biria Mazda  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 5, 2008-01 ,pp. : 297-303

Adis International

Access to resources Recommend Favorite

Statins in Heart Failure—Where Do We Stand?

By Lyons Kristopher   McVeigh Gary   Harbinson Mark  

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 1, 2011-02 ,pp. : 99-104

Springer Publishing Company

Access to resources Recommend Favorite

Genetics of Hypertrophic and Dilated Cardiomyopathy

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 13, 2012-10 ,pp. : 2467-2476

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy of Dilated Cardiomyopathy

By  

Current Pharmaceutical Design, Vol. 21, Iss. 4, 2015-02 ,pp. : 449-458

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidized Low Density Lipoproteins-Do We Know Enough About Them?

By Jiang Xueting  

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 5, 2011-10 ,pp. : 367-377

Springer Publishing Company

Access to resources Recommend Favorite